Big Pharma Vs. Washington – An Opportunity To Buy Merck & Co. (MRK)

Warren Buffett states, “Uncertainty is the friend of the buyer of long-term values,” and Washington represents a big question mark these days for the pharmaceutical sector.

After all, news broke on Friday that Bristol Myers Squibb

BMY
has sued Uncle Sam over a Medicare price renegotiation program in the Inflation Reduction Act (IRA) that was passed last August. The pharmaceutical giant’s litigation comes on the heels of similar action from rival Merck & Co.
MRK
, which called the program a “sham” and “extortion.”